Cargando…
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report
BACKGROUND: Coronavirus disease 2019 (COVID-19) has spread worldwide. Vaccination is now recommended as one of the effective countermeasures to control the pandemic or prevent the worsening of symptoms. However, its adverse effects have been attracting attention. Here, we report an autopsy case of m...
Autores principales: | Kaimori, Ryo, Nishida, Haruto, Uchida, Tomohisa, Tamura, Mari, Kuroki, Kohji, Murata, Kumi, Hatakeyama, Kinta, Ikeda, Yoshihiko, Amemiya, Kisaki, Nishizono, Akira, Daa, Tsutomu, Mori, Shinjiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540301/ https://www.ncbi.nlm.nih.gov/pubmed/36203145 http://dx.doi.org/10.1186/s12959-022-00418-7 |
Ejemplares similares
-
Érythème pigmenté fixe après vaccin anti-COVID-19 Comirnaty® de Pfizer/BioNTech
por: Lellig, Elodie, et al.
Publicado: (2021) -
Subacute monomelic radiculoplexus neuropathy following Comirnaty© (Pfizer-BioNTech COVID-19) vaccination: A case report
por: Coly, M., et al.
Publicado: (2023) -
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022) -
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)